Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits QuantWave's Price Target Forecast with 22.06% Profit

August 08, 2023
ELI LILLY AND COMPANY's stock has successfully achieved the price target forecast set by QuantWave, resulting in a remarkable profit of 22.06%. The forecast signal was issued on May 4, 2023, with the stock price at 421.28 $. The predicted direction was long, and on August 8, 2023, the price hit 514.21 $, meeting the target.

The achievement of this forecast showcases the accuracy and reliability of QuantWave's analytics in predicting stock movements. Market analysis indicates that several factors contributed to ELI LILLY AND COMPANY's stock performance, including positive company earnings, strong industry outlook, and favorable market conditions.

QuantWave's automated forecasting platform offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For investors seeking to enhance their understanding of the investment strategy behind QuantWave, exploring the educational resources of QuantSchool is recommended. QuantSchool provides a comprehensive professional investment framework, unveiling the key principles for generating consistent income through the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

CVXOctober 27, 2023QuantWave Achieves 5.08% Profit Target Forecast for Chevron Corporation  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit its price target forecast for Chevron Corporation's stock....

ZTSApril 8, 2025QuantWave Achieves Profit of 12.47% in ZOETIS INC. Stock Forecast  ~1 min.

QuantWave, an automated forecasting platform, successfully reached its price target forecast for ZOETIS INC. with a profit of 12.47%....

KTNovember 22, 2024KT CORPORATION Hits Price Target Forecast with 24.53% Profit - QuantWave Analysis  ~1 min.

KT CORPORATION has successfully reached the price target forecast set by QuantWave, resulting in a profit of 24.53%. The forecast signal was initiated on August 6, 2024, with the stock priced at 13.33 $....

ATOMay 6, 2025ATMOS ENERGY CORPORATION Hits Price Target Forecast on QuantWave, Providing 8.99% Profit Opportunity  ~1 min.

ATMOS ENERGY CORPORATION's stock has successfully reached the price target forecast set by QuantWave on 2025-03-07, signaling a long position at a price of 147.78 $....

HDSeptember 19, 2024The Home Depot, Inc. Stock Hits Price Target Forecast with 27.46% Profit  ~1 min.

QuantWave, a leading automated forecasting platform, successfully predicted the price movement of The Home Depot, Inc. stock on February 8, 2023....